While healthcare organizations around the world grapple with the ongoing COVID-19 pandemic, hackers continue to bombard the busy industry with increasingly sophisticated cybercrimes. Ransomware attacks, in particular, have noticeably skyrocketed since the coronavirus outbreak started. Just this May 2020, healthcare giant Magellan Health fell victim to a ransomware attack that compromised its corporate servers.
As cyberattacks become increasingly sophisticated, cybersecurity leaders also continue to look for more effective ways to protect business data. Today, organizations are warming up to the idea of shifting from the “trust, but verify” mantra to a “never trust, always verify” approach. In a zero-trust architecture, all users are treated as potential threats and are not allowed to access data unless properly authenticated.
Since the beginning of 2019, the number of biosimilar litigation - particularly those concerning the Biologics Price Competition and Innovation Act (BPCIA) “patent dance” - has drastically increased. One of the notable BCPIA cases that are being closely watched, is Amgen’s legal battle with Novartis’ Sandoz arm over the Enbrel patent, in which the former intends to hold commercial exclusivity for Enbrel until 2029. The legal precedents established in this dispute are expected to impact the biosimilar market as well as the pending and future biosimilar patent lawsuits.
Also known as claim construction hearing, the Markman hearing is a significant proceeding in a patent infringement case. Getting it right is crucial to the success of a case.
Ransomware remains a pervasive threat to businesses throughout many industries. As this type of cyberattack continues to increase and become more sophisticated, companies grapple to seek new and effective ways to protect their security systems. Putting preventive measures in place is good; however, organizations should go beyond just prevention.
The number of cyberattacks and fraudulent acts has been proliferating rapidly. Fraudsters have successfully made their way to access a victim’s financial resources through different schemes like stealing a victim’s personally identifiable information (PII).
QA automation has been prevalent over decades in the Software Testing Industry, and it's continuing to mature to pace up with a wide variety of technologies, programming languages, and methodologies. While QA automation has helped enhance the test coverage, lower overall QA costs, and accelerate test cycles; however, we’ve only touched the tip of the iceberg.
Synthetic identity fraud remains to be a vexing problem for many financial institutions and organizations today. With its widespread impact and continuing proliferation, it is considered one of the fastest-growing types of financial crimes in the U.S. Significantly, without a comprehensive understanding of synthetic identity fraud, detection can become an increasingly difficult task. Although banks and other companies have been investing in technologies that offer help, financial crimes continue to surface, chiefly due to the lack of solutions that focus on detection and prevention.
In this LIVE Webcast, a panel of thought leaders and professionals brought together by The Knowledge Group will provide and present an in-depth analysis of the fundamentals as well as recent developments in eDiscovery and Litigation Preparedness: Tools, Tactics, and Best Practices to Leverage. Speakers will also present all important issues surrounding this significant topic. Join us for this Knowledge Group Webinar!
Data governance is a crucial tool to ensure proper management and protection of data assets within an organization. It establishes precise methods to standardize business procedures, creates clear internal rules for changing processes, helps ensure risk management and optimization, and supports compliance with privacy and security regulations.
Today’s businesses are significantly maximizing the potentials of cloud-based workforce mobility tools for improved productivity and more advanced workforce management. However, the increase of users, devices, and applications accessing outside the enterprise perimeter has resulted in a rise of cyberattacks and data breaches.
Digital supply chain is currently gaining prominent recognition due to its greater versatility as compared to traditional supply chains. Because cybersecurity risks and third-party attacks have skyrocketed at an alarming rate, more businesses now prefer the digital way. However, cyber-related supply chain threats are always almost impossible to prevent. As businesses seek to leverage the potentials of this growing tool, new challenges also start to emerge.
As the world develops and distributes safe and effective vaccines against COVID-19, the pharmaceutical industry is confronted with additional trade secrets protection challenges. Issues include the increased the burdens of protecting their assets, the immense level of R&D, the substantial impact of remote work, and COVID-related legal restrictions. Pharmaceutical companies must implement effective trade secrets protection strategies to manage threats amidst this crisis.
Today’s cyber-vulnerable digital environment continues to pose a plethora of security issues to organizations of all sizes. This underscores the importance of securing a reliable cybersecurity framework to prevent these increasingly sophisticated cyberattacks from compromising a business.
The number of data breach incidents has continuously ramped up at an alarming pace. As the digital world progresses, cybercriminals have found various ways to infiltrate confidential and sensitive business data, posing profound risks of business disruption, financial losses, and reputational damages. To mitigate these, businesses and their cybersecurity experts must ensure that their sensitive data are safeguarded. They must come up with data security measures and policies as well as cybersecurity assessment tools and strategies to avoid potential data breaches.
